Toreforant, identified by its CAS number 952494-46-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is classified as a selective antagonist of the histamine H4 receptor, which plays a significant role in various physiological processes, including immune response and inflammation. The compound's structure features specific functional groups that contribute to its biological activity and receptor selectivity. In preclinical studies, Toreforant has shown promise in modulating immune responses, making it a candidate for treating conditions such as allergic diseases and autoimmune disorders. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile in clinical settings. As research continues, further insights into its mechanism of action and potential side effects will be essential for evaluating its therapeutic viability. Overall, Toreforant represents a noteworthy advancement in the exploration of histamine receptor-targeted therapies.

Toreforant

952494-46-1: Toreforant, identified by its CAS number 952494-46-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is classified as a selective antagonist of the histamine H4 receptor, which plays a significant role in various physiological processes, including immune response and inflammation. The compound's structure features specific functional groups that contribute to its biological activity and receptor selectivity. In preclinical studies, Toreforant has shown promise in modulating immune responses, making it a candidate for treating conditions such as allergic diseases and autoimmune disorders. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile in clinical settings. As research continues, further insights into its mechanism of action and potential side effects will be essential for evaluating its therapeutic viability. Overall, Toreforant represents a noteworthy advancement in the exploration of histamine receptor-targeted therapies.

Toreforant is an effective and selective histamine H4 receptor antagonist (Ki at the human receptor: 8.4 nM).

CAS 952494-46-1

Toreforant

Toreforant

Ref: TR-T547515

Toreforant

Ref: 3D-BT166504

Toreforant

Ref: TM-T17118